Sponsored Content
Recent Posts
- ApoE4 Alzheimer’s Alliance launched as US advocacy group May 2, 2025
- Leqembi approved in EU as treatment for early Alzheimer’s April 21, 2025
- Simufilam fails to meet Phase 3 trial goals; development discontinued April 4, 2025
- Menopause, synapse health may interact to raise Alzheimer’s risk March 7, 2025
- Leqembi IV monthly maintenance dosing approved by FDA February 7, 2025